Cargando…

A reproducible mouse model of chronic allograft nephropathy with vasculopathy

While short-term outcomes in kidney transplantation have improved dramatically, long-term survival remains a major challenge. A key component of long-term, chronic allograft injury in solid organ transplants is arteriosclerosis characterized by vascular neointimal hyperplasia and inflammation. Estab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zarjou, Abolfazl, Guo, Lingling, Sanders, Paul W., Mannon, Roslyn B., Agarwal, Anupam, George, James F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495090/ https://www.ncbi.nlm.nih.gov/pubmed/22874842 http://dx.doi.org/10.1038/ki.2012.277

Ejemplares similares

A Small Molecule β2 Integrin Agonist Improves Chronic Kidney Allograft Survival by Reducing Leukocyte Recruitment and Accompanying Vasculopathy
por: Khan, Samia Q., et al.
Publicado: (2014)

Chronic allograft nephropathy
por: Fletcher, Jeffery T., et al.
Publicado: (2009)

A Reproducible Mouse Model of Moderate CKD With Early Manifestations of Osteoblastic Transition of Cardiovascular System
por: Machado, Sarah E, et al.
Publicado: (2022)

Interleukin 21 (IL-21) regulates chronic allograft vasculopathy (CAV) in murine heart allograft rejection
por: Khattar, Mithun, et al.
Publicado: (2019)

Risk factors of cardiac allograft vasculopathy
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2015)

Melatonin Synergizes With Mesenchymal Stromal Cells Attenuates Chronic Allograft Vasculopathy
por: Qin, Ya-fei, et al.
Publicado: (2021)

Early Cardiac Allograft Vasculopathy: Are the Viruses to Blame?
por: Aggarwal, Ashim, et al.
Publicado: (2012)

Cardiac allograft vasculopathy: diagnosis, therapy, and prognosis
por: Skorić, Boško, et al.
Publicado: (2014)

Coronary CTA for Surveillance of Cardiac Allograft Vasculopathy
por: Shah, Nishant R., et al.
Publicado: (2018)

The role of everolimus in treatment of cardiac allograft vasculopathy
por: Watanabe, Tetsu
Publicado: (2013)

The novel proteomic signature for cardiac allograft vasculopathy
por: Wei, Dongmei, et al.
Publicado: (2022)

Coronary allograft vasculopathy managed by Flash ostial balloon in a pediatric patient
por: Desai, Viral K., et al.
Publicado: (2021)

Corrigendum: Melatonin Synergizes With Mesenchymal Stromal Cells Attenuates Chronic Allograft Vasculopathy
por: Qin, Ya-fei, et al.
Publicado: (2021)

What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy?
por: Kobashigawa, Jon
Publicado: (2000)

Cardiac allograft vasculopathy in Dutch heart transplant recipients
por: Galli, G., et al.
Publicado: (2016)

Correction to: Coronary CTA for Surveillance of Cardiac Allograft Vasculopathy
por: Shah, Nishant R., et al.
Publicado: (2018)

Effect of Statin Intensity on the Progression of Cardiac Allograft Vasculopathy
por: Ellimuttil, Tracey M, et al.
Publicado: (2021)

Diagnosis of chronic allograft vasculopathy using semiquantitative stress perfusion CMR in heart transplant patients
por: Schwid, Madeline, et al.
Publicado: (2016)

Inhibition of Chemokine-Glycosaminoglycan Interactions in Donor Tissue Reduces Mouse Allograft Vasculopathy and Transplant Rejection
por: Dai, Erbin, et al.
Publicado: (2010)

3-dimensional digital reconstruction of the murine coronary system for the evaluation of chronic allograft vasculopathy
por: Fónyad, László, et al.
Publicado: (2015)

miR‐21 antagonism reprograms macrophage metabolism and abrogates chronic allograft vasculopathy
por: Usuelli, Vera, et al.
Publicado: (2021)

Multiparametric cardiovascular magnetic resonance assessment of cardiac allograft vasculopathy
por: Miller, Christopher A, et al.
Publicado: (2014)

Cardiac Allograft Vasculopathy: A Donor or Recipient Induced Pathology?
por: van den Hoogen, Patricia, et al.
Publicado: (2015)

Far-Infrared Therapy Decreases Orthotopic Allograft Transplantation Vasculopathy
por: Lin, Yi-Wen, et al.
Publicado: (2022)

Vascular rejection in cardiac allograft vasculopathy: Impact on graft survival
por: Nair, Nandini
Publicado: (2022)

Epicardial fat volume is related to the degree of cardiac allograft vasculopathy
por: Roest, Stefan, et al.
Publicado: (2022)

Factors associated with cardiac allograft vasculopathy after heart transplantation
por: Szczurek-Wasilewicz, Wioletta, et al.
Publicado: (2022)

Cardiac allograft vasculopathy diagnosed by vasodilator myocardial contrast echocardiography perfusion imaging
por: Prasad, Pooja, et al.
Publicado: (2023)

Neutrophil mediated smooth muscle cell loss precedes allograft vasculopathy
por: King, Chelsey L, et al.
Publicado: (2010)

Quantitative coronary computed tomography angiography for the detection of cardiac allograft vasculopathy
por: Foldyna, Borek, et al.
Publicado: (2020)

Pharmacological vs Exercise Stress Echocardiography for Detection of Cardiac Allograft Vasculopathy
por: Gebska, Milena A., et al.
Publicado: (2020)

Multiparametric Cardiac Magnetic Resonance Imaging for Diagnosing Cardiac Allograft Vasculopathy
por: Lee, Ji Won
Publicado: (2022)

An agent-based model of cardiac allograft vasculopathy: toward a better understanding of chronic rejection dynamics
por: Serafini, Elisa, et al.
Publicado: (2023)

Small Molecule Tyrosine Kinase Inhibitor Nintedanib Reduces Development of Cardiac Allograft Vasculopathy in Murine Aortic Allografts
por: Gocht, Annika, et al.
Publicado: (2018)

Early Inflammatory Markers Are Independent Predictors of Cardiac Allograft Vasculopathy in Heart-Transplant Recipients
por: Labarrere, Carlos A., et al.
Publicado: (2014)

Progression of cardiac allograft vasculopathy assessed by serial three-vessel quantitative coronary angiography
por: Zanchin, Christian, et al.
Publicado: (2018)

Experimental rat models of chronic allograft nephropathy: a review
por: Shrestha, Badri, et al.
Publicado: (2014)

AAV-Mediated Expression of AP-1-Neutralizing RNA Decoy Oligonucleotides Attenuates Transplant Vasculopathy in Mouse Aortic Allografts
por: Remes, Anca, et al.
Publicado: (2019)

Extracellular HMGB1 Contributes to the Chronic Cardiac Allograft Vasculopathy/Fibrosis by Modulating TGF-β1 Signaling
por: Zou, Huijuan, et al.
Publicado: (2021)

Association of CD14(+) monocyte-derived progenitor cells with cardiac allograft vasculopathy
por: Salama, Mohamed, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_occsh80drjl6iueg966tjpqe24